Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10145 (
IL-8
)
23,849
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
LPA (lysophosphatidic acid) is a potent bioactive phospholipid, which regulates a number of diverse cellular responses through G protein-coupled LPA receptors. Intracellular LPA is generated by the phosphorylation of monoacylglycerol by
acylglycerol kinase
(
AGK
); however, the role of intracellular LPA in signaling and cellular responses remains to be elucidated. Here, we investigated signaling pathways of
IL-8
secretion mediated by
AGK
and intracellular LPA in human bronchial epithelial cells (HBEpCs). Expression of
AGK
in HBEpCs was detected by real-time PCR, and overexpressed
AGK
was mainly localized in mitochondria as determined by immunofluorescence and confocal microscopy. Overexpression of lentiviral
AGK
wild type increased intracellular LPA production ( approximately 1.8-fold), enhanced LPA-mediated
IL-8
secretion, and stimulated tyrosine phosphorylation epidermal growth factor-receptor (EGF-R). Furthermore, downregulation of native
AGK
by
AGK
small interfering RNA decreased intracellular LPA levels ( approximately 2-fold) and attenuated LPA-induced p38 MAPK, JNK, and NF-kappaB activation, tyrosine phosphorylation of EGF-R, and
IL-8
secretion. These results suggest that native
AGK
regulates LPA-mediated
IL-8
secretion involving MAPKs, NF-kappaB, and transactivation of EGF-R. Thus
AGK
may play an important role in innate immunity and airway remodeling during inflammation.
...
PMID:Role of acylglycerol kinase in LPA-induced IL-8 secretion and transactivation of epidermal growth factor-receptor in human bronchial epithelial cells. 1911 1